| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Pharmacyclics, Inc., Sunnyvale, California and 2 Institute for Genetic Medicine, University of Southern California, Los Angeles, California
Requests for reprints: Darren Magda, Pharmacyclics, Inc., 995 E. Arques Avenue, Sunnyvale, CA 94085. Phone: 408-774-3318; Fax: 408-328-3689; E-mail: dmagda{at}pcyc.com.
There is an emerging appreciation of the importance of zinc in regulating cancer cell growth and proliferation. Recently, we showed that the anticancer agent motexafin gadolinium (MGd) disrupted zinc metabolism in A549 lung cancer cells, leading, in the presence of exogenous zinc, to cell death. Here, we report the effect of MGd and exogenous zinc on intracellular levels of free zinc, oxidative stress, proliferation, and cell death in exponential phase human B-cell lymphoma and other hematologic cell lines. We find that increased levels of oxidative stress and intracellular free zinc precede and correlate with cell cycle arrest and apoptosis. To better understand the molecular basis of these cellular responses, gene expression profiling analyses were conducted on Ramos cell cultures treated with MGd and/or zinc acetate. Cultures treated with MGd or zinc acetate alone elicited transcriptional responses characterized by induction of metal response elementbinding transcription factor-1 (MTF-1)regulated and hypoxia-inducible transcription factor-1 (HIF-1)regulated genes. Cultures cotreated with MGd and zinc acetate displayed further increases in the levels of MTF-1 and HIF-1regulated transcripts as well as additional transcripts regulated by NF-E2related transcription factor 2. These data provide insights into the molecular changes that accompany the disruption of intracellular zinc homeostasis and support a role for MGd in treatment of B-cell hematologic malignancies. (Cancer Res 2005; 65(24): 11676-88)
This article has been cited by other articles:
![]() |
J. R. Kirshner, S. He, V. Balasubramanyam, J. Kepros, C.-Y. Yang, M. Zhang, Z. Du, J. Barsoum, and J. Bertin Elesclomol induces cancer cell apoptosis through oxidative stress Mol. Cancer Ther., August 1, 2008; 7(8): 2319 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Magda, P. Lecane, Z. Wang, W. Hu, P. Thiemann, X. Ma, P. K. Dranchak, X. Wang, V. Lynch, W. Wei, et al. Synthesis and Anticancer Properties of Water-Soluble Zinc Ionophores Cancer Res., July 1, 2008; 68(13): 5318 - 5325. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, E. Abdel Fattah, G. Cao, C. Ren, G. Yang, A. A. Goltsov, A. C. Chinault, W.-W. Cai, T. L. Timme, and T. C. Thompson Glioma Pathogenesis-Related Protein 1 Exerts Tumor Suppressor Activities through Proapoptotic Reactive Oxygen Species c-Jun NH2 Kinase Signaling Cancer Res., January 15, 2008; 68(2): 434 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Baker, T. Landowski, R. Dorr, W. R. Tate, J. M.C. Gard, B. E. Tavenner, T. Dragovich, A. Coon, and G. Powis The Antitumor Agent Imexon Activates Antioxidant Gene Expression: Evidence for an Oxidative Stress Response Clin. Cancer Res., June 1, 2007; 13(11): 3388 - 3394. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Evans, F. Xu, M. Sirisawad, R. Miller, L. Naumovski, and P. R. O. de Montellano Motexafin Gadolinium-Induced Cell Death Correlates with Heme oxygenase-1 Expression and Inhibition of P450 Reductase-Dependent Activities Mol. Pharmacol., January 1, 2007; 71(1): 193 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Poulsen, R. Borup, N. Borregaard, F. C. Nielsen, M. B. Moller, and E. Ralfkiaer Prognostic significance of metallothionein in B-cell lymphomas Blood, November 15, 2006; 108(10): 3514 - 3519. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ramos, M. Sirisawad, R. Miller, and L. Naumovski Motexafin gadolinium modulates levels of phosphorylated Akt and synergizes with inhibitors of Akt phosphorylation Mol. Cancer Ther., May 1, 2006; 5(5): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |